Skip to main content
. 2021 Jun 22;11(36):22057–22069. doi: 10.1039/d1ra03770f
F68
K (M−1) graphic file with name d1ra03770f-t22.jpg graphic file with name d1ra03770f-t23.jpg graphic file with name d1ra03770f-t24.jpg
Cytarabine
298.15 (4.8 ± 0.1) × 102 −(0.4 ± 0.01) 50.2 ± 1.0 −(15.3 ± 0.3)
303.15 (5.7 ± 0.1) × 102 −(0.3 ± 0.01) 51.8 ± 1.0 −(16.0 ± 0.3)
308.15 (8.3 ± 0.2) × 102 −(0.3 ± 0.05) 55.0 ± 1.1 −(17.2 ± 0.3)
313.15 (9.3 ± 0.2) × 102 −(0.3 ± 0.06) 56.0 ± 1.1 −(17.8 ± 0.4)
Gemcitabine
298.15 (6.2 ± 0.1) × 103 19.1 ± 0.38 136.5 ± 2.7 −(21.6 ± 0.4)
303.15 (7.8 ± 0.2) × 103 13.5 ± 0.27 119.1 ± 2.4 −(22.6 ± 0.5)
308.15 (8.7 ± 0.1) × 103 8.7 ± 0.17 101.7 ± 2.0 −(22.6 ± 0.4)
313.15 (2.1 ± 0.6 × 103 2.1 ± 0.04 83.2 ± 1.5 −(24.0 ± 0.4)
Hydroxyurea
298.15 (4.7 ± 0.1) × 102 −(0.4 ± 0.1) 49.8 ± 0.9 −(15.2 ± 0.3)
303.15 (5.2 ± 0.9) × 102 −(0.4 ± 0.2) 50.8 ± 1.0 −(15.3 ± 0.3)
308.15 (7.2 ± 0.4) × 102 −(0.4 ± 0.1) 53.4 ± 1.1 −(16.3 ± 0.3)
313.15 (7.9 ± 0.5) × 102 −(0.4 ± 0.1) 54.2 ± 1.1 −(17.4 ± 0.3)